Akili (AKLI) Competitors

$0.44
+0.04 (+9.46%)
(As of 05:37 PM ET)

AKLI vs. MDAI, RVP, NMTC, MODD, FEMY, LNSR, ICU, CODX, CTCX, and XAIR

Should you be buying Akili stock or one of its competitors? The main competitors of Akili include Spectral AI (MDAI), Retractable Technologies (RVP), NeuroOne Medical Technologies (NMTC), Modular Medical (MODD), Femasys (FEMY), LENSAR (LNSR), SeaStar Medical (ICU), Co-Diagnostics (CODX), Carmell (CTCX), and Beyond Air (XAIR). These companies are all part of the "surgical & medical instruments" industry.

Akili vs.

Spectral AI (NASDAQ:MDAI) and Akili (NASDAQ:AKLI) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their earnings, valuation, dividends, community ranking, risk, profitability, media sentiment, analyst recommendations and institutional ownership.

Akili received 5 more outperform votes than Spectral AI when rated by MarketBeat users. However, 100.00% of users gave Spectral AI an outperform vote while only 66.67% of users gave Akili an outperform vote.

CompanyUnderperformOutperform
Spectral AIOutperform Votes
1
100.00%
Underperform Votes
No Votes
AkiliOutperform Votes
6
66.67%
Underperform Votes
3
33.33%

67.1% of Spectral AI shares are held by institutional investors. Comparatively, 53.1% of Akili shares are held by institutional investors. 56.7% of Spectral AI shares are held by insiders. Comparatively, 10.1% of Akili shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Spectral AI has a net margin of 0.00% compared to Spectral AI's net margin of -3,545.47%. Akili's return on equity of 0.00% beat Spectral AI's return on equity.

Company Net Margins Return on Equity Return on Assets
Spectral AIN/A N/A -118.02%
Akili -3,545.47%-76.34%-56.48%

Spectral AI currently has a consensus target price of $4.00, suggesting a potential upside of 138.10%. Akili has a consensus target price of $4.00, suggesting a potential upside of 800.09%. Given Spectral AI's higher probable upside, analysts plainly believe Akili is more favorable than Spectral AI.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Spectral AI
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00
Akili
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00

In the previous week, Spectral AI had 3 more articles in the media than Akili. MarketBeat recorded 5 mentions for Spectral AI and 2 mentions for Akili. Akili's average media sentiment score of 0.49 beat Spectral AI's score of 0.00 indicating that Spectral AI is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Spectral AI
1 Very Positive mention(s)
0 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Akili
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Spectral AI has a beta of 0.61, suggesting that its stock price is 39% less volatile than the S&P 500. Comparatively, Akili has a beta of 1.7, suggesting that its stock price is 70% more volatile than the S&P 500.

Spectral AI has higher revenue and earnings than Akili.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Spectral AI$18.06M1.63-$20.85MN/AN/A
Akili$1.68M20.82-$59.49M-$0.76-0.58

Summary

Spectral AI beats Akili on 9 of the 14 factors compared between the two stocks.

Get Akili News Delivered to You Automatically

Sign up to receive the latest news and ratings for AKLI and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding AKLI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

AKLI vs. The Competition

MetricAkiliSurgical & medical instruments IndustryMedical SectorNASDAQ Exchange
Market Cap$34.93M$3.89B$5.03B$7.78B
Dividend YieldN/A2.14%2.78%3.96%
P/E Ratio-0.5820.31166.6319.03
Price / Sales20.8262.542,374.0885.35
Price / CashN/A45.3233.7128.61
Price / Book0.594.215.334.62
Net Income-$59.49M$4.59M$105.33M$217.48M
7 Day Performance8.71%-0.99%0.55%1.43%
1 Month Performance82.43%-4.83%-3.44%-2.25%
1 Year Performance-64.45%8.06%3.69%9.86%

Akili Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
MDAI
Spectral AI
4.3451 of 5 stars
$1.78
-4.3%
$4.00
+124.7%
N/A$31.10M$18.06M0.0078News Coverage
RVP
Retractable Technologies
0 of 5 stars
$1.07
-0.9%
N/A-31.3%$32.03M$43.60M-4.46148Upcoming Earnings
NMTC
NeuroOne Medical Technologies
1.2418 of 5 stars
$1.13
+0.9%
$2.20
+94.7%
-16.2%$29.30M$1.95M-1.6616Gap Up
MODD
Modular Medical
2.9946 of 5 stars
$1.57
-3.7%
$4.25
+171.6%
-2.3%$34.27MN/A-1.6137
FEMY
Femasys
2.7733 of 5 stars
$1.27
-3.8%
$11.33
+792.4%
+85.2%$28.07M$1.07M-1.3832Analyst Forecast
News Coverage
Gap Down
LNSR
LENSAR
3.1092 of 5 stars
$3.12
+4.0%
$8.00
+156.4%
+24.2%$35.57M$42.16M-1.74130News Coverage
Gap Up
ICU
SeaStar Medical
0 of 5 stars
$0.48
-5.9%
N/A-77.6%$36.22MN/A-0.4012Gap Up
CODX
Co-Diagnostics
3.225 of 5 stars
$1.16
-0.9%
$2.50
+115.5%
-11.6%$36.26M$6.81M-0.96155News Coverage
CTCX
Carmell
0 of 5 stars
$2.00
flat
N/AN/A$38.50MN/A0.009Gap Up
XAIR
Beyond Air
3.5459 of 5 stars
$1.08
+0.9%
$11.25
+941.7%
-76.8%$38.92MN/A-0.5198Positive News

Related Companies and Tools

This page (NASDAQ:AKLI) was last updated on 5/9/2024 by MarketBeat.com Staff

From Our Partners